Fluorescence characterization of organic matter and fouling: Case study in a full-scale reverse osmosis membrane treatment plant.

Membranes used for water treatment are subject to organic fouling, caused by organic matter in source water. Characterizing organic matter has the potential to improve fouling prediction since the development of an organic fouling layer on the membrane is dependent on the specific characteristics of the organic matter. A field study was performed at a full-scale reverse osmosis water treatment plant that treats secondary wastewater effluent for industrial reuse at a power plant. Samples were collected at various points within the treatment process and were analyzed for turbidity, total organic carbon (TOC), conductivity, and fluorescence Excitation Emission Matrices (EEM). Parallel factor analysis (PARAFAC) was used to generate representative fluorescence measurements of the organic matter. Results indicate that TOC and fluorescence measurements were effective in differentiating between two observed fouling periods at multiple locations within the treatment plant. However, none of the water quality measurements were effective in tracking treatability of organic matter throughout pretreatment. The results of this case study provide important information about the relationship between fluorescence NOM signals and membrane fouling that can be used in future online detection systems. PRACTITIONER POINTS: TOC and fluorescence measurements were effective in differentiating between the high fouling and low fouling periods. Water quality measurements were not effective in tracking changes in organic matter throughout pretreatment. Implementation of online fluorescence monitoring of fouling potential could be used for real-time process control.

Limit of stokesian settling concentration characterizes sludge settling velocity.

Flocculent settling (stokesian) is predominant within ideally operating clarifiers, and the shift to 'slower' hindered settling (non-stokesian) causes both failure and poor effluent quality. Therefore, a new metric for settling characteristics was developed and classified as Limit of Stokesian Settling (LOSS). The technique consisted of determining the total suspended solids (TSS) concentration at which mixed liquor settling characteristics transition from stokesian to non-stokesian settling. An image analytical technique was developed with the aid of MATLAB(®) to identify this transition. The MATLAB tool analyzed RGB images from video, and identified the presence of an interface by a dramatic shift in the Red indices. LOSS data for Secondary activated-sludge systems were analyzed for a period of 60 days at the Blue Plains Advanced Wastewater Treatment Plant. LOSS for secondary systems typically occurred between 600 and 700 mg TSS/L but reached 1000 mg TSS/L for a good settling secondary sludge and 500 mg TSS/L for a poor settling secondary sludge, settling quality was based on hindered settling rates. In addition, LOSS was collected for granular systems seeded with cyclone underflow from Strass Wastewater Treatment Plant, it was observed that LOSS was higher for granular systems ranging from 1600 to 5500 mg TSS/L for low and high levels of granulation, respectively. The monovalent to divalent cation ratio (M/D) was increased with the addition of sodium ions to deteriorate settling properties. Samples adjusted with higher M/D consistently had 100 mg TSS/L (15%) decrease in LOSS from the control. LOSS numbers collected experimentally were validated with the Takacs et al. (1991) settling model. When compared to flux curves with small changes in sludge matrix, LOSS was proven to be faster at characterizing hindered settling velocity and was less erratic. This is the first time a measurement method has been developed to characterize the transition from stokesian to non-stokesian settling. Additionally, this is the first step in developing new metrics to predict clarifier failure, and determine effluent quality through the development of flocculent settling metrics.

Polyelectrolyte and silver nanoparticle modification of microfiltration membranes to mitigate organic and bacterial fouling.

Membrane fouling remains one of the most problematic issues surrounding membrane use in water and wastewater treatment applications. Organic and biological fouling contribute to irreversible fouling and flux decline in these processes. The aim of this study was to reduce both organic and biological fouling by modifying the surface of commercially available poly(ether sulfone) (PES) membranes using the polyelectrolyte multilayer modification method with poly(styrenesulfonate) (PSS), poly(diallyldimethylammonium chloride) (PDADMAC), and silver nanoparticles (nanoAg) integrated onto the surface as stable, thin (15 nm) films. PSS increases the hydrophilicity of the membrane and increases the negative surface charge, while integration of nanoAg into the top PSS layer imparts biocidal characteristics to the modified surface. Fouling was simulated by filtering aqueous solutions of humic acid (5 and 20 mg L(-1)), a suspension of Escherichia coli (10(6) colony-forming units (CFU) mL(-1)), and a mixture of both foulants through unmodified and modified PES membranes under batch conditions. Filtration and cleaning studies confirmed that the modification significantly reduced organic and biological fouling.

Benefits of newborn screening for cystic fibrosis in Shreveport, Louisiana, Cystic Fibrosis Center.

INTRODUCTION: Cystic Fibrosis (CF) is the second most common, life-shortening, inherited disorder occurring in childhood in the United States, after sickle cell anemia. More than 10 million Americans are unknowing, symptomless carriers of the defective cystic fibrosis gene. Cystic Fibrosis was included in the newborn heel stick screening in Louisiana, beginning July 2007. AIMS AND OBJECTIVES: 1) To assess and compare the nutritional status of Cystic Fibrosis patients in the newborn screened cohort (NBS) compared to the non-newborn screened cohort (non-NBS) by measuring their weight for length/height percentile at 1, 2, and 3 years of age, 2) To compare the vitamin levels of CF patients in these two groups, 3) To compare the number of hospitalizations in the two groups, and 4) To compare the incidence of colonization of significant bacteria in the airways in these groups. METHODOLOGY: Out of 91 CF patients, 26 were excluded due to insufficient data. The sample was stratified into two groups; 1) Newborn screen (July 2007 to present) and 2) Non-Newborn screen (1971 to present). Recording and comparison of their weight for height or length; percent of patients showing decreased fat soluble vitamin A, D, and E levels; rate of hospitalization; and cultures at 1- 3 years of age were made. RESULTS: CF patients below 50th percentile of weight for height/length were 48.88% in Non-NBS and 33.33% in NBS at one year, 47.73% in Non-NBS and 40% in NBS at two years, and 45.45% in Non-NBS and 25% in NBS at three years. CF patients below 10th percentile of weight for height/length were 13.33% in the Non-NBS and 5% in NBS at one year, 11.66% in Non-NBS and 0% in NBS at two years, and 6.81% in Non-NBS and 8.33% in NBS at three years of age. There was also reduction of vitamin A, D, and E deficiencies at one to three years in NBS compared to Non-NBS. However, these results were not statistically significant. The hospitalization rate of CF patients during the first three years of life was 86.66% in Non-NBS as compared to 68.42% in NBS. The colonization of (i) MRSA was 18.75% in Non-NBS and 36.84% in NBS, and (ii) Pseudomonas aeruginosa in Non-NBS was 59.37% and 36.84% in NBS at any point during the first three years. CONCLUSION: The study has shown that there has been an improvement in the nutritional status shown by a decrease in the percentage of patients below the 50th percentile and below 10th percentile of weight for height at one to three years of age after the implementation of NBS three years ago. There has also been a reduction in the vitamin deficiencies, hospitalizations, and colonization by Pseudomonas aeruginosa among the screened patients as compared to the CF patients diagnosed clinically.

Decreasing uncertainties in assessing environmental exposure, risk, and ecological implications of nanomaterials.

Determining the fate and interactions of nanomaterials in complex environmental contexts is required to assess exposure and possible harm as well as to inform regulation. As the nanotechnology industry moves up into the rarified air of trillion dollar economics over the next several years (1), the number of simple and complex manufactured nanomaterials (NMs), and their uses, will grow tremendously. Large-scale production of engineered NMs presents the possibility that organisms and ecosystems may be exposed to new levels and qualities of substances with unknown consequences. Naturally occurring nanoscale materials are also ubiquitous in the biosphere, comprising the very building blocks of life and likely playing an important role in ecosystem

Evidence for environmental contamination in residential neighborhoods surrounding the defense depot of Memphis, Tennessee.

An interdisciplinary environmental assessment team from the Howard University Environmental Justice Partnership (HUEJP) conducted a site visit and assessment of the Defense Depot of Memphis, Tennessee in February of 2000. This depot was built in the late 1940's for storage of numerous chemicals and munitions. As the years progressed, many Memphis citizens have grown to believe that the activities and chemical stockpile located at this site have negatively affected the health environment of their residents. There is anecdotal evidence and documentation of numerous cancers and other illnesses in those local territories, and specifically, at the Memphis Depot site. Currently, this depot is closed and in remediation by the local government. Particularly, citizens of the Rozelle community have started a campaign to investigate any signs of exposure pathways to noted health risks. The HUEJP was contacted and asked to investigate the community concerns. Obliging to the request, we aimed to sample at three drainage sites and a residential site, talk to local citizens, and gain any additional information that would be helpful in relieving anxiety in the Rozelle community. Soil, sediment, and water samples were collected and analyzed for total organic carbon, inorganic anions, and heavy metals. These data show that for the four sites sampled, the highest concentrations of organic compounds and heavy metals were located either within a residential area or in an area with a direct transport pathway to the community. Atomic absorption analysis revealed detectable amounts of cadmium, lead and chromium metals at all sites with direct transport pathways into the residential community, with chromium concentrations being far in excess of the EPA standard limits.

Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: evidence for antecedent hypoxia.

OBJECTIVES: Recurrent hypoxemia has been proposed as an important pathophysiological mechanism underlying sudden infant death syndrome (SIDS). However, conflicting results emerged when xanthines were used as markers for hypoxia. The vascular endothelial growth factor (VEGF) gene is highly sensitive to changes in tissue partial oxygen tension, and changes in genomic and protein expression occur even after changes in oxygenation within the physiologic range. METHODS: For determining whether hypoxia precedes SIDS, VEGF levels were measured using an enzyme-linked immunosorbent assay in the cerebrospinal fluid (CSF) of 51 SIDS infants and in 33 additional control infants who died of an identifiable cause. In addition, 6 rats that had a chronically implanted catheter in the lateral ventricle were exposed to a short hypoxic challenge, and VEGF concentrations were measured in CSF at various time points for 24 hours. Another set of 6 rats were killed with a pentobarbital overdose, and VEGF CSF levels were obtained at different time points after death. RESULTS: Mean VEGF concentrations in CSF were 308.2 +/- 299.1 pg/dL in the SIDS group and 85.1 +/- 82.9 pg/dL in those who died of known causes. Mean postmortem delay averaged 22 hours for both groups. In rat experiments, hypoxic exposures induced time-dependent increases in VEGF, peaking at 12 hours and returning to baseline at 24 hours. Postmortem duration in the animals was associated with gradual increases in VEGF that reached significance only at 36 hours. CONCLUSIONS: We conclude that VEGF CSF concentrations are significantly higher in infants who die of SIDS. We postulate that hypoxia is a frequent event that precedes the sudden and unexpected death of these infants.

Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.

BACKGROUND: Etiology of dialysis induced hypotension and hypertension remains speculative. There is mounting evidence that nitric oxide (NO) and endothelin (ET-1) may play a vital role in these hemodynamic changes. We examined the intradialytic dynamic changes in NO and ET-1 levels and their role in the pathogenesis of hypotension and rebound hypertension during hemodialysis (HD). METHODS: The serum nitrate + nitrite (NT), fractional exhaled NO concentration (FENO), L-arginine (L-Arg), NGNG-dimethyl-L-arginine (ADMA) and endothelin (ET-1) profiles were studied in 27 end-stage renal disease (ESRD) patients on HD and 6 matched controls. The ESRD patients were grouped according to their hemodynamic profile; Group I patients had stable BP throughout HD, Group II had dialysis-induced hypotension, and Group III had intradialytic rebound hypertension. RESULTS: Pre-dialysis FENO was significantly lower in the dialysis patients compared to controls (19.3 +/- 6.3 vs. 28.6 +/- 3.4 ppb, P < 0.002). Between the experimental groups, pre-dialysis FENO was significantly higher in Group II (24.1 +/- 6.7 ppb) compared to Group I (17.8 +/- 5.6 ppb) and Group III (16.1 +/- 4.2 ppb; P < 0.05). Post-dialysis, FENO increased significantly from the pre-dialysis values (19.3 +/- 6.3 vs. 22.6 +/- 7.9 ppb; P=0.001). Pre-dialysis NT (34.4 +/- 28.2 micromol/L/L) level was not significantly different from that of controls (30.2 +/- 12.3 micromol/L/L). Serum NT decreased from 34.4 +/- 28.2 micromol/L/L at initiation of dialysis to 10.0 +/- 7.4 micormol/L/L at end of dialysis (P < 0.001). NT concentration was comparable in all the three groups at all time points. Pre-dialysis L-Arg (105.3 +/- 25.2 vs. 93.7 +/- 6.0 micromol/L/L; P < 0.05) and ADMA levels were significantly higher in ESRD patients (4.0 +/- 1.8 vs. 0.9 +/- 0.2 micromol/L/L; P < 0.001) compared to controls. Dialysis resulted in significant reduction in L-Arg (105.3 +/- 25.2 vs. 86.8 +/- 19.8 micromol/L/L; P < 0.005) and ADMA (4.0 +/- 1.8 vs. 1.6 +/- 0.7 micromol/L/L; P < 0.001) concentrations. Pre-dialysis ET-1 levels were significantly higher in ESRD patients compared to the controls (8.0 +/- 1.9 vs. 12.7 +/- 4.1 pg/mL; P < 0.002), but were comparable in the three study groups. Post-dialysis ET-1 levels did not change significantly in Group I compared to pre-dialysis values (14.3 +/- 4.3 vs.15.0 +/- 2.4 pg/mL, P=NS). However, while the ET-1 concentration decreased significantly in Group II (12.0 +/- 4.0 vs. 8.7 +/- 1.8 pg/mL, P < 0.05), it increased in Group III from pre-dialysis levels (12.8 +/- 3.8 vs. 16.7 +/- 4.5 pg/mL, P=0.06). CONCLUSION: Pre-dialysis FENO is elevated in patients with dialysis-induced hypotension and may be a more reliable than NT as a marker for endogenous NO activity in dialysis patients. Altered NO/ET-1 balance may be involved in the pathogenesis of rebound hypertension and hypotension during dialysis.

Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea.

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is associated with intermittent hypoxia during sleep. Vascular endothelial growth factor (VEGF) has detectable levels in the circulation and its expression is highly regulated by oxygen tension. We therefore hypothesized that serum VEGF levels will be elevated in patients with OSA. DESIGN: Blood samples were collected at random times during the day from 68 adults and 41 children who were clinically suspected for the presence of OSA, and who underwent overnight polysomnography. SETTING: University hospital sleep laboratory. PARTICIPANTS: N/A. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: For both children and adults, serum VEGF levels were significantly higher in polysomnographically confirmed OSA (AHI>15 and AI>5 in adults and children respectively) when compared to those with mild or no disease (p<0.0001). Furthermore, significant correlations were found between VEGF concentrations and respiratory disturbance index and sleep time spent at SpO2 <90%. In addition, VEGF levels in children were higher for any given duration of hypoxia during sleep (p<0.0001). No differences in VEGF emerged between evening and morning samples. However, temporal delays in blood sample processing were associated with spuriously increased VEGF concentrations. Exploratory analysis of the data revealed that serum VEGF concentrations of >150 pg/ml in adults and >100 pg/ml in children were predictive of OSA, when an apnea-hypopnea index >30 and an apnea index >5 were used as disease criteria in adults and children, respectively. CONCLUSIONS: We conclude that circulating VEGF levels are frequently elevated in OSA patients, and may play a role in the regulation of tissue oxygen delivery.